Ann: Quarterly Activity Report and Appendix 4C for Q2 FY2023, page-7

It appears that each I-Med site is averaging a bit over $25K revenue per quarter. That's with XV only and without a Medicare rebate. Adding 18 new centres for the quarter, implying that a target in this year of 100 sites, each turning over $100K p.a. is doable. That's an I-Med centric observation, with other radiology offerings from clinics and hospitals representing a larger market again.

The I-Med rollout learning curve will begin to flatten for 4DMedical and I would hope that they'll be not only more efficient in the rollout this year, but that the attention of radiology industry will be asking themselves why they are not in this business.

I suspect that a Medicare rebate will provide a further kicker. More than a few times, my own GP has shown caution about patients' cost burden on certain scans.

An exciting show in '23 for Australian revenue. But a blockbuster is brewing in the US.